Tenure: A System Built on Coercion Tenure: A System Built on Coercion
Academic medicine depends on us giving away our labor for free. Why do we keep doing it?Medscape Blogs (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 28, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology Blog Source Type: news

Fifth COVID Shot Recommended for Patients With Cancer Fifth COVID Shot Recommended for Patients With Cancer
The National Comprehensive Cancer Network says those who are immunocompromised should get a second mRNA boaster against COVID.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 28, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Non-O Blood Type May Increase VTE Risk in Patients With Cancer Non-O Blood Type May Increase VTE Risk in Patients With Cancer
Non-O blood type appears to be associated with a higher risk of venous thromboembolism (VTEs) in some patients with cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 27, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Total Resection for Glioblastoma Predicts Longer Survival Total Resection for Glioblastoma Predicts Longer Survival
Most notably, the team found that frailty had no effect on surgical outcomes. The study was published as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 27, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Best CRC Treatment De-intensification: Better Screening Best CRC Treatment De-intensification: Better Screening
Mark Lewis, MD, discusses the decline in colorectal cancer screening during the COVID-19 pandemic and his hopes for the future.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 27, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

A'Wake-Up' Call to Resolve UK Cancer Drug Access A'Wake-Up' Call to Resolve UK Cancer Drug Access
David Kerr questions the policy that patients in Scotland with prostate cancer have access to olaparib, yet patients in the rest of the United Kingdom do not.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 26, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

The Mental Health Sacrifice of IMGs' Search for Perfection The Mental Health Sacrifice of IMGs' Search for Perfection
Medical students must be perfect in everything they do. But that pursuit of"perfection" can have devastating consequences.Medscape Blogs (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 26, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology Blog Source Type: news

EMA Begins Review of Rucaparib After Finding of Shorter Survival EMA Begins Review of Rucaparib After Finding of Shorter Survival
Recently published results from the ARIEL4 trial show a significantly longer progression-free survival; but new results show a shorter overall survival.News Alerts (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 26, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Breast-Conserving Surgery Safe for Deeply Seated Breast Cancer Breast-Conserving Surgery Safe for Deeply Seated Breast Cancer
The inframammary breast-conserving approach for deep-seated tumors led to acceptable cosmetic results in 82% of cases. The study was published as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 25, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

APOA2 May Serve as a New Biomarker for Gastric Cancer APOA2 May Serve as a New Biomarker for Gastric Cancer
APOA2 is over-expressed in gastric cancer tumor samples and may affect overall survival for patients. The study was published as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 25, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Pinterest Rife With Misleading Cancer Nutrition Info Pinterest Rife With Misleading Cancer Nutrition Info
Cancer-related nutrition"pins" often claim to prevent, treat, or cure cancer, with many pinners selling dubious products or services to patients and survivors.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 22, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Cancer Hospitals' Drug Price Markups Can Exceed 600% Cancer Hospitals' Drug Price Markups Can Exceed 600%
Owing to hospital cancer drug markups, the total price for a treatment course could vary by hundreds of thousands of dollars, new research finds.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 21, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Gendered Expectations of Physician Accessibility Gendered Expectations of Physician Accessibility
A research paper validates an oncologist ' s lived experience with gender-biased workloads, especially related to the EHR, as her daily clinic experience differed vastly from that of many of her male counterparts.Medscape Blogs (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 21, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology Blog Source Type: news

Oncogene-Positive Lung Cancer: What Therapy to Start? Oncogene-Positive Lung Cancer: What Therapy to Start?
Dr Mark Kris discusses the choice between chemotherapy and targeted therapy in patients with lung cancer and oncogenic drivers.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 20, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

PD-L1 Test Debated in Gastroesophageal Cancer Immunotherapy PD-L1 Test Debated in Gastroesophageal Cancer Immunotherapy
Clinicians are wondering whether measuring programmed death –ligand 1 (PD-L1) is essential before prescribing checkpoint inhibitors for gastroesophageal cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 20, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news